<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82317">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01930448</url>
  </required_header>
  <id_info>
    <org_study_id>03-108</org_study_id>
    <nct_id>NCT01930448</nct_id>
  </id_info>
  <brief_title>Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1</brief_title>
  <official_title>Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's-Roosevelt Hospital Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Luke's-Roosevelt Hospital Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric bypass (GBP) and laparoscopic adjustable banding (AGB) are common procedures that
      can result in significant weight loss and significantly improve type 2 diabetes in 40-80% of
      cases.  The mechanism and time course of these changes have not been well studied and are
      poorly understood. The primary aim of this study is to investigate the potential
      weight-independent mechanisms of diabetes remission after GBP, by comparing GBP and AGB
      subjects after similar weight loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participants will be tested before and then after 10 and 20-30% weight loss after either
      GBP or AGB surgery. Subjects will undergo an oral glucose tolerance test (OGTT) an
      isoglycemic intravenous glucose test (IVGT) to assess the incretin effect, a measure of
      insulin sensitivity by an intravenous insulin sensitivity test (IVGTT) and body composition
      measurements.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2008</start_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in Incretin Effect</measure>
    <time_frame>Before surgery, 1, 12, and 24 months post</time_frame>
    <safety_issue>No</safety_issue>
    <description>Effect of GBP and AGB on incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Body Composition</measure>
    <time_frame>Before surgery,  12, and 24 months post</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body composition measurements to determine body volume, size, and fat</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gastric Bypass Surgery</condition>
  <condition>Gastric Banding</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>gastric bypass</arm_group_label>
    <description>Surgical group of obese patients with type 2 diabetes undergoing gastric bypass surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gastric banding</arm_group_label>
    <description>surgical group of obese patients with type 2 diabetes undergoing gastric banding</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        severly obese patients with type 2 diabetes undergoing gastric bypass or gastric banding
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obese type 2 diabetes individuals scheduled to undergo bariatric surgery by either
             gastric banding or gastric bypass surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Blandine Laferrere, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Obesity Nutrition Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carolina Espinosa, MS</last_name>
    <phone>2125233581</phone>
  </overall_contact>
  <location>
    <facility>
      <name>St. Luke's Roosevelt Hospital-New York Obesity Nutrition Research Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Blandine Laferrere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>August 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bariatric</keyword>
  <keyword>Gastric Bypass</keyword>
  <keyword>Gastric Banding,</keyword>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Incretins</keyword>
  <keyword>GLP-1</keyword>
  <keyword>GIP</keyword>
  <keyword>Insulin secretion</keyword>
  <keyword>insulin sensitivity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
